BRENTFORD GROUP PRACTICE
BOSTON MANOR ROAD, BRENTFORDHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 2 | 2 | 100.0% | |
HF 4 | 2011 | 3 | 4 | 75.0% | |
HF 4 | 2012 | 3 | 4 | 75.0% | |
HF 4 | 2013 | 5 | 6 | 83.3% | |
HF004 | 2014 | 3 | 3 | 100.0% | |
HF004 | 2015 | 7 | 7 | 100.0% | |
HF004 | 2016 | 15 | 16 | 93.8% | |
HF004 | 2017 | 23 | 24 | 95.8% | |
HF004 | 2018 | 25 | 28 | 89.3% | |
HF004 | 2019 | 30 | 33 | 90.9% | |
HF004 | 2020 | 32 | 34 | 94.1% | |
HF006 | 2021 | 35 | 40 | 87.5% | |
HF006 | 2022 | 40 | 45 | 88.9% | |
HF006 | 2023 | 39 | 42 | 92.9% |